Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Romel Somwar

10PUBLICATIONS
98CO-AUTHORS
Molecular targetsChemical engineering design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

Sort by Publication Date:
|Mar 11, 2026
FET Fusion Oncoproteins Disrupt Physiologic DNA Repair and Create a Targetable Opportunity for ATR Inhibitor Therapy.

Daniel E Gracilla, Shruti Menon, Marcus R Breese

|Jan 16, 2026
RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236.

Alexander J Pfeil, Tom Zhang, Ryan Cheng

|May 31, 2025
Drug tolerance and persistence to EGFR inhibitor treatment are mediated by an ILK-SFK-YAP signaling axis in lung adenocarcinoma.

Rocky Shi, Dylan A Farnsworth, Christopher A Febres-Aldana

|Feb 18, 2025
Pan-Cancer Analysis of Oncogenic MET Fusions Reveals Distinct Pathogenomic Subsets with Differential Sensitivity to MET-Targeted Therapy.

Christopher A Febres-Aldana, Morana Vojnic, Igor Odintsov

|Sep 30, 2024
Preclinical evaluation of targeted therapies for central nervous system metastases.

Alexander J Pfeil, Joshua D Hale, Tiger S Zhang

|Aug 09, 2024
HER2 Antibody-Drug Conjugates Are Active against Desmoplastic Small Round Cell Tumor.

Tom Zhang, Christopher A Febres-Aldana, Zebing Liu

Pageof 2

Frequent Collaborators

7 joint publications

Marc Ladanyi

4 joint publications

Elisa de Stanchina

3 joint publications

Marissa S Mattar

3 joint publications

Allan J W Lui

3 joint publications

Christopher A Febres-Aldana

3 joint publications

Monika A Davare

3 joint publications

Leo Gili

3 joint publications

Ryan Cheng

3 joint publications

Tom Zhang

3 joint publications

Soo-Ryum Yang

Frequent Collaborators

7 joint publications

Marc Ladanyi

4 joint publications

Elisa de Stanchina

3 joint publications

Marissa S Mattar

3 joint publications

Allan J W Lui

Top Related Videos

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on : Jul 05, 2019

10.1K
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on : Jul 17, 2019

6.5K
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

8.9K
See more related videos

Top Related Videos

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on : Jul 05, 2019

10.1K
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on : Jul 17, 2019

6.5K
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

8.9K
See more related videos